351 related articles for article (PubMed ID: 31461550)
1. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
[TBL] [Abstract][Full Text] [Related]
3. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
4. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
5. Treatment for HIV-associated cryptococcal meningitis.
Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
[TBL] [Abstract][Full Text] [Related]
9. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
[TBL] [Abstract][Full Text] [Related]
10. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
11. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
[TBL] [Abstract][Full Text] [Related]
13. Combination antifungal therapy for cryptococcal meningitis.
Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.
Villanueva-Lozano H; Treviño-Rangel RJ; González GM; Hernández-Rodríguez PA; Camacho-Ortiz A; Castillo-Reyna L; Galindo-Alvarado SG; Martínez-Reséndez MF
Infection; 2018 Feb; 46(1):25-30. PubMed ID: 28815430
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
Lofgren S; Abassi M; Rhein J; Boulware DR
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
[TBL] [Abstract][Full Text] [Related]
16. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
18. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
[TBL] [Abstract][Full Text] [Related]
19. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
20. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
